ArticlePloS one2026
Identification of BmSP25 gene in Bombyx mori with antiviral function against BmNPV.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bombyx mori serine protease (BmSP) is constitute a gene family of proteolytic enzymes characterized by serine residues at their active sites and play critical roles in physiological processes, including digestion, growth and development, and immune responses. As a member of the BmSP family, BmSP25 exhibits differential expression following Bombyx mori nucleopolyhedrovirus (BmNPV) infection. Our result demonstrated that BmNPV infection upregulated BmSP25 expression in both resistant (SuN) and susceptible (P50) silkworm strains, with a more pronounced response observed in SuN than in P50. To further investigate its function, siRNA-mediated knockdown of BmSP25 in BmN cells promoted the proliferation of recombinant BV-EGFP virus, whereas overexpression of BmSP25 significantly suppressed BmNPV replication. To validate its antiviral activity at the organismal level, transgenic silkworm strains overexpressing BmSP25 (BmSP25-OE) and BmSP25 knockout strains (BmSP25-KO) were generated. Following oral inoculation with BmNPV, viral proliferation was significantly inhibited in the BmSP25-OE strain, whereas viral replication was notably enhanced in the BmSP25-KO strain. This study is the first to clearly demonstrate the anti-BmNPV function of BmSP25 in silkworms, providing a foundation for further elucidation of its role in host immune defense mechanisms and identifying a potential genetic target for molecular breeding aimed at improving disease resistance in silkworms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.